Remove tag
article thumbnail

Haemophilia drug costing $3.5m per dose has been approved

Pharmafile

CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price tag. CSL Behring’s Hemgenix is a one-dose treatment which appeared to reduce the number of bleeding events by 54% over the course of a year. Costing $3.5m read more.

72
article thumbnail

Viseven at Reuters Pharma EU

Viseven

This April was truly intense for Viseven in terms of events: weeks after visiting New York, our team went on to Reuters Pharma 2023 in Barcelona, while Korea Bio & Pharma meeting took place in Seoul the same weekend. For that matter, the attendees could choose between three stages and a more quiet lunch zone for personal communication.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

3 ways pharma marketers can draw inspiration from digitally-native brands

pharmaphorum

“Digitally native brands are typically agile businesses from the ground up, and agility and flexibility are part of their core makeup,” says Joe Holmes, vice president, marketing services, US at Tag. Jeremy Richter, Tag. Joe began his life at Tag in the UK, bringing efficiencies to his clients, working across all conceivable channels.

article thumbnail

ASH: Argenx cues up a second use for efgartigimod

pharmaphorum

Adverse events such as bruising, headaches, and blood in urine occurred at roughly the same frequency in both groups of patients in ADVANCE IV, and while serious side effects were seen in 8% of the Vyvgart group, that was lower than the 16% reported with placebo.

article thumbnail

Biogen’s Aduhelm rollout goes from bad to worse

pharmaphorum

Vounatsos also insisted that Aduhelm’s price tag has not been a factor discouraging treatment with the drug.

118
118
article thumbnail

Timeular Review - A fun system to keep track of daily work productivity

The Digital Apothecary

This included only being available through a browser and need to tracking time after the event, lack of syncing between a mobile device and computer, data collection and reporting were only offered under a premium service, etc. This was a must, and I what I like is I can #tag actions (e.g., Ability to keep notes on activities.

130
130
article thumbnail

Orphan drugs and where to launch them: The keys to Europe’s forgotten territories

Pharmaceutical Technology

Due to the high price tags associated with these speciality medicines, innovators have naturally favoured big markets with high GDP such as the US and EU-5 (Germany, France, Spain, Italy, and the UK). “The Go-to-market strategies. The choice of where to launch an orphan drug is an important and difficult decision.